These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 21044399)

  • 1. Switching cholinesterase inhibitors in older adults with dementia.
    Massoud F; Desmarais JE; Gauthier S
    Int Psychogeriatr; 2011 Apr; 23(3):372-8. PubMed ID: 21044399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The benefits and risks associated with cholinesterase inhibitor therapy in Alzheimer's disease.
    Thompson S; Lanctôt KL; Herrmann N
    Expert Opin Drug Saf; 2004 Sep; 3(5):425-40. PubMed ID: 15335298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Which cholinesterase inhibitor is the safest for the heart in elderly patients with Alzheimer's disease?
    Isik AT; Bozoglu E; Yay A; Soysal P; Ateskan U
    Am J Alzheimers Dis Other Demen; 2012 May; 27(3):171-4. PubMed ID: 22573283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholinesterase inhibitors: tremor and exacerbation of Parkinson's disease.
    Prescrire Int; 2007 Oct; 16(91):197-8. PubMed ID: 17926835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's disease: beware of interactions with cholinesterase inhibitors.
    Prescrire Int; 2006 Jun; 15(83):103-6. PubMed ID: 16764099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bradycardia due to cholinesterase inhibitors: identify adverse effects and take them into account.
    Prescrire Int; 2011 Apr; 20(115):95. PubMed ID: 21648211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changing the anticholinesterase in Alzheimer's disease].
    Olazarán-Rodríguez J; Navarro-Merino E
    Rev Neurol; 2005 Jun 16-30; 40(12):739-42. PubMed ID: 15973641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of an effect size analysis for communicating treatment effectiveness: a case study of cholinesterase inhibitors for Alzheimer's disease.
    Peters KR
    J Am Geriatr Soc; 2013 Jul; 61(7):1170-4. PubMed ID: 23711226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cholinesterase inhibitors on postoperative outcomes of older adults with dementia undergoing hip fracture surgery.
    Seitz DP; Gill SS; Gruneir A; Austin PC; Anderson G; Reimer CL; Rochon PA
    Am J Geriatr Psychiatry; 2011 Sep; 19(9):803-13. PubMed ID: 21873836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of cholinesterase-inhibitor use in the nursing home setting: a retrospective analysis.
    Dybicz SB; Keohane DJ; Erwin WG; McRae T; Shah SN
    Am J Geriatr Pharmacother; 2006 Jun; 4(2):154-60. PubMed ID: 16860262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Alzheimer drugs: life-threatening adverse effects.
    Prescrire Int; 2007 Feb; 16(87):16. PubMed ID: 17326275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer's disease.
    Di Santo SG; Prinelli F; Adorni F; Caltagirone C; Musicco M
    J Alzheimers Dis; 2013; 35(2):349-61. PubMed ID: 23411693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discontinuation of cholinesterase inhibitor treatment and determinants thereof in the Netherlands: A retrospective cohort study.
    Kröger E; van Marum R; Souverein P; Egberts T
    Drugs Aging; 2010 Aug; 27(8):663-75. PubMed ID: 20658794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies for continued successful treatment of Alzheimer's disease: switching cholinesterase inhibitors.
    Gauthier S; Emre M; Farlow MR; Bullock R; Grossberg GT; Potkin SG
    Curr Med Res Opin; 2003; 19(8):707-14. PubMed ID: 14687441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotic Initiation Among Older Dementia Patients Using Cholinesterase Inhibitors: A National Retrospective Cohort Study.
    Rege S; Carnahan RM; Johnson ML; Chen H; Holmes HM; Aparasu RR
    Drugs Aging; 2021 Jun; 38(6):493-502. PubMed ID: 33763822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successfully switching acetylcholinesterase inhibitor therapy in probable Lewy body dementia.
    Alwahhabi FK
    J Psychopharmacol; 2005 Mar; 19(2):214-6. PubMed ID: 15728444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of Serious Adverse Events Associated With Individual Cholinesterase Inhibitors Use in Older Adults With Dementia: A Population-Based Cohort Study.
    Masurkar PP; Chatterjee S; Sherer JT; Chen H; Johnson ML; Aparasu RR
    Drugs Aging; 2022 Jun; 39(6):453-465. PubMed ID: 35666463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effect of cholinesterase inhibitor medications on recognition memory performance in mild to moderate Alzheimer's disease: preliminary findings.
    Crowell TA; Paramadevan J; Abdullah L; Mullan M
    J Geriatr Psychiatry Neurol; 2006 Mar; 19(1):13-5. PubMed ID: 16449754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cholinesterase inhibitor therapy in long term care settings].
    Vantelon C; Gilbert S; Kerneis S; Wolmark Y; Legrain S; Kergoat MJ
    Rev Med Interne; 2006 Aug; 27(8):588-94. PubMed ID: 16806591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cholinesterase inhibitors in the treatment of dementia--are they useful in clinical practice?].
    Landmark K; Reikvam A
    Tidsskr Nor Laegeforen; 2008 Jan; 128(3):294-7. PubMed ID: 18264153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.